Scientific Research & Development Services
Scientific research and development services (NAICS 5417): Basic and applied research, drug discovery, biotechnology, contract R&D, and technology development services driving US competitiveness.
Industry at a Glance
Sector-wide aggregates across all businesses classified under NAICS 5417 (2017 classification frame). For specific sub-industries within this sector, see the individual reports below.
Industry Overview
Scientific research and development services (NAICS 5417) encompasses establishments primarily engaged in conducting original investigation undertaken on a systematic basis to gain new scientific or technical knowledge, as well as applying research findings to develop new or improved products and processes. This industry group includes basic research, applied research, and experimental development activities conducted by both public and private institutions, ranging from pharmaceutical and biotechnology research to materials science, nanotechnology, and environmental studies. As a driver of technological advancement, this sector strengthens economic competitiveness, supports breakthrough discoveries, and generates intellectual property that fuels commercialization across virtually every other industry. The sector is characterized by high capital intensity, significant personnel investment in highly educated scientists and engineers, and long development timelines from conception to marketable outcomes.
Who Uses These Reports
Trusted by professionals who need verified federal data to make decisions
Investors & PE Firms
Size markets, validate deal theses, and benchmark targets with verified federal data before committing capital
Consultants & Advisors
Deliver data-backed recommendations to clients with sourced and cited industry metrics — Census, BLS, and FRED
Founders & Operators
Validate market entry, benchmark against industry averages, and present credible data to investors and boards
Corporate Strategy Teams
Support expansion planning, M&A due diligence, and executive reporting with NAICS-classified industry data
See what's inside a report
Market sizing, workforce analysis, competitive landscape, regulatory environment — all sourced from Census, BLS, FRED, and SEC EDGAR.
Industry Trends
Accelerating growth in contract research organization (CRO) services as pharmaceutical and biotechnology companies increasingly outsource R&D activities to specialized service providers for cost efficiency and specialized expertise.
Expanding investment in artificial intelligence and machine learning applications for drug discovery, materials modeling, and research data analysis, reshaping traditional research methodologies and accelerating development cycles.
Rising demand for research services in sustainable technologies, clean energy, and climate adaptation as government policies and corporate sustainability commitments drive funding toward environmental and green chemistry research.
Increased collaboration between private sector R&D services and academic institutions, facilitated by technology transfer offices and partnerships that commercialize university research discoveries.
Growing regulatory complexity and compliance requirements driving demand for specialized R&D services in regulatory consulting, clinical trial management, and quality assurance alongside traditional scientific research.
Specialty Reports Available on Request
4 specialty industriesavailable on request▾
Industries
Browse deeper into the NAICS hierarchy.
Frequently Asked Questions
What is NAICS 5417? ▾
NAICS 5417 is the classification for establishments engaged in scientific research and development services, encompassing both basic research aimed at advancing scientific knowledge and applied research designed to develop practical applications. This includes activities such as pharmaceutical research, biotechnology development, materials testing, environmental research, and experimental development across physical, life, and engineering sciences. The industry serves as a bridge between scientific discovery and commercialization, enabling technological advancement across all economic sectors.
What types of organizations operate in this industry? ▾
The industry includes independent research institutes, contract research organizations (CROs), pharmaceutical and biotech R&D divisions, materials testing laboratories, environmental research firms, and research centers operated by universities and government agencies. Organizations range from small specialized boutique firms focusing on niche research areas to large multinational corporations with substantial R&D budgets and diverse research portfolios spanning multiple scientific disciplines.
How do R&D services companies generate revenue? ▾
Revenue is generated through multiple channels including government research grants and contracts (particularly from federal agencies like NIH, NSF, and DOE), sponsored research agreements with pharmaceutical and industrial companies, licensing of intellectual property and patents, contract research services on a fee-for-service basis, and milestone-based payments from commercialization partnerships. Funding models vary significantly based on organization type, with academic research centers relying heavily on government funding while private CROs depend primarily on corporate client contracts.
What is the difference between basic research and applied research in this industry? ▾
Basic research, also called fundamental research, is conducted to advance scientific knowledge without immediate commercial application, often exploring fundamental scientific principles and phenomena. Applied research uses existing scientific knowledge to develop practical approaches and new products or processes for specific commercial or industrial purposes. While basic research generates the foundational knowledge, applied research translates these discoveries into viable technologies and products that can be commercialized and brought to market.
How does intellectual property factor into R&D services? ▾
Intellectual property is central to the industry's value creation, with patents, trade secrets, and proprietary methodologies representing significant assets developed through research activities. R&D service providers must carefully manage IP ownership agreements with clients through licensing arrangements and work-for-hire contracts, while also protecting their own proprietary platforms and techniques. Many firms generate substantial revenue through patent licensing and technology transfer agreements that allow commercialization partners to use developed intellectual property.
Related Guides
Accounting, tax and bookkeeping corporations made a 12.0% pretax margin after losses in 2022 (IRS SOI); profitable ones alone 15.1%. How it ranks.
Verified accounting industry trends from federal data. 1.3M+ workers across 137K+ establishments (Census CBP, 2023). Employment, automation, and market outlook.
US advertising agencies employ 200K+. Digital and programmatic shift, agency model change, AI in media buying, and the 2026 outlook.
Consulting corporations made a 7.7% pretax margin after losses in 2022 (IRS SOI); profitable ones alone 11.8%. What drives it and how it varies.
Get verified consulting industry trends data from federal sources. US Management Consulting Employment: 1.4M+ (Bureau of Labor Statistics, 2024).
Questions about how we source industry data? See our data sources FAQ.
Don't see your industry?
We can generate a report for any NAICS-classified industry in the US. Professional PDF delivered in 48 hours.